Condition

Molecular Pathway Deregulation clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Molecular Pathway Deregulation clinical trials that are recruiting, at sites in 3 countries (most in South Korea (1), Pakistan (1), France (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Molecular Pathway Deregulation clinical trials

StudyPhaseWhereStatusRegistered
Examining the biological features of early breast cancer in Pakistani women — Jamshoro Recruiting Feb 17, 2025
Characteristics of Colon Cancer in Young Patients — Seongnam-si, Gyeonggi-do Recruiting May 9, 2022
Identifying genes in systemic autoinflammatory diseases — Paris Recruiting May 6, 2022

All recruiting trials (3)

Related topics

Breast CancerColo-rectal CancerGenetic DiseaseInflammatory DiseaseMolecular Sequence VariationSomatic Mutation

Quick answers

How many Molecular Pathway Deregulation clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in South Korea (1 trial), Pakistan (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.